✦ LIBER ✦

The expanding clinical spectrum of Anderson–Fabry disease: a challenge to diagnosis in the novel era of enzyme replacement therapy

✍ Scribed by A. C. Hauser; M. Lorenz; G. Sunder-Plassmann

Book ID: 108861866
Publisher: John Wiley and Sons
Year: 2004
Tongue: English
Weight: 166 KB
Volume: 255
Category: Article
ISSN: 0954-6820
DOI: 10.1111/j.1365-2796.2004.01300.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Fabry disease in the era of enzyme repla

Fabry disease in the era of enzyme replacement therapy: a renal perspective

✍ MoniqueE. Cho; JeffreyB. Kopp 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 513 KB

A novel mutation of the GAA gene in a Fi

A novel mutation of the GAA gene in a Finnish late-onset pompe disease patient: Clinical phenotype and follow-up with enzyme replacement therapy

✍ Mari P. Korpela; Anders Paetau; Mervi I. Löfberg; Marjut H. Timonen; Antti E. La 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 139 KB

## Abstract Pompe disease is a rare, progressive disease leading to skeletal muscle weakness due to deficiency of the acid α‐glucosidase (GAA) enzyme. Herein we report the first diagnosed Finnish patient with a phenotype compatible with the late‐onset form of Pompe disease. Molecular genetic analys